CENTRAL LINE ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI)

Clinical trials for CENTRAL LINE ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI) explained in plain language.

Never miss a new study

Get alerted when new CENTRAL LINE ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI) trials appear

Sign up with your email to follow new studies for CENTRAL LINE ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Breakthrough infection fighter for home feeding tubes enters final testing

Prevention Recruiting now

This study is testing whether a new solution called DefenCath can prevent dangerous bloodstream infections in adults who receive nutrition through a feeding tube at home. Researchers will compare DefenCath against the standard heparin solution in 200 participants over 12 months t…

Matched conditions: CENTRAL LINE ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI)

Phase: PHASE3 • Sponsor: CorMedix • Aim: Prevention

Last updated Mar 19, 2026 14:55 UTC

CENTRAL LINE ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI)

Get alerted when new CENTRAL LINE ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI) trials appear

Breakthrough infection fighter for home feeding tubes enters final testing